← Leaderboards
Akiva Kosowsky
A And G Pharmaceutical, Inc.
$238,533
Attributed
$238,533
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $122.1K · FY2023–24$200K$150K$100K$50K$0
'23
'24
Funding mix
By agency
NIH$238,533 · 1
By mechanism
N01$238,533 · 1
Top collaborators
No co-investigators on record.
Most similar at A And G Pharmaceutical, Inc.
Same institution · by research overlap
- Jun Hayashi Hayashi$184,029
Others in their field
Other Rising Stars on “Toxicokinetics”
- Colin Osborne · University Of Texas Med Br Galveston$10,407,745
- Alexander Kolykhalov · Emory University$8,116,465
- Debra Burnin · Sri International$5,524,121
- John Parkinson · Thetis Pharmaceuticals, Llc$5,120,562
- Dawn Fallacara · Battelle Centers/Pub Hlth Res & Evaluatn$3,618,654
- George Cox · Bolder Biotechnology, Inc.$3,079,369
Research focus
ToxicokineticsCell LineCongenital Myasthenic SyndromesDrug CandidateDrug KineticsGene TherapyImmunogenicityMethod DevelopmentMonoclonal AntibodiesNational Center For Advancing Translational SciencesAffinityEpitopesAntibodiesLabelDocumentationPre-ClinicalPreparationPolyclonal AntibodyGenerations
Grant awards (3)
TASK ORDER 7 - DOK7$105,670
N01 · FY2024 · DA · contact PI
TO6 - GENERATING MONOCLONAL CELL LINES, MONOCLONAL ANTIBODIES, AND LABELED MONOCLONAL ANTIBODIES AGAINST HUMAN AND MOUSE COLQ$16,463
N01 · FY2024 · DA · contact PI
TO6 - GENERATING MONOCLONAL CELL LINES, MONOCLONAL ANTIBODIES, AND LABELED MONOCLONAL ANTIBODIES AGAINST HUMAN AND MOUSE COLQ$116,400
N01 · FY2023 · DA · contact PI